Middle East respiratory syndrome. The Lancet, vol.395, pp.1063-1077, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02100825
Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features, Infect Dis Clin North Am, vol.33, issue.4, pp.869-889, 2019. ,
, Coronavirus disease (COVID-2019) situation reports
,
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, Travel Med Infect Dis, p.101791, 2020. ,
,
, Healthcare workers & SARS-CoV-2 infection in India: a casecontrol investigation in the time of COVID-19, Indian J Med Res, vol.151, issue.5, pp.459-467, 2020.
Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives -a better synergy for future COVID-19 clinical trials, Infez Med, vol.28, pp.192-197, 2020. ,
Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas, Epidemiol Infect, vol.148, p.124, 2020. ,
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?, J Thromb Thrombolysis, 2020. ,
The trinity of COVID-19: immunity, inflammation and intervention, Nat Rev Immunol, 2020. ,
Detection of SARS-CoV-2 in Different Types of Clinical Specimens, JAMA, 2020. ,
Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China, Kidney Int, vol.98, issue.1, pp.219-227, 2020. ,
Myocardial localization of coronavirus in COVID-19 cardiogenic shock, Eur J Heart Fail, vol.22, issue.5, pp.911-915, 2020. ,
Evidence for Gastrointestinal Infection of SARS-CoV-2, Gastroenterology, vol.158, issue.6, pp.1831-1833, 2020. ,
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses, Biochem Biophys Res Commun, vol.526, issue.1, pp.135-140, 2020. ,
Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis, Intensive Care Med, vol.46, issue.6, pp.1114-1116, 2020. ,
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues, Cell, 2020. ,
Multiorgan and Renal Tropism of SARS-CoV-2, N Engl J Med, 2020. ,
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients, J Thromb Thrombolysis, 2009. ,
Brief Report: Anti-phospholipid antibodies in critically ill patients with Coronavirus Disease 2019 (COVID-19). Arthritis Rheumatol, 2020. ,
Anti-cardiolipin IgG autoantibodies are an independent risk factor of COVID-19 severity. Arthritis Rheumatol, 2020. ,
High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?, J Intern Med, 2020. ,
Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020. Emerg Infect Dis, vol.26, 2020. ,
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19, N Engl J Med, vol.8, p.38, 2020. ,
Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection, Hematol Oncol Stem Cell Ther, 2020. ,
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, vol.426, issue.6965, pp.450-454, 2003. ,
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry, J Virol, vol.85, issue.2, pp.873-882, 2011. ,
Thrombosis as an intravascular effector of innate immunity, Nat Rev Immunol, vol.13, issue.1, pp.34-45, 2013. ,
A third of coronavirus cases may be 'silent carriers', classified Chinese data suggests. South China Morning Post, 2020. ,
,
Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med, 2020. ,
COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet, 2020. ,
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study, Sig Transduct Target Ther, vol.5, issue.1, p.33, 2020. ,
Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment, Cell, vol.159, issue.6, pp.1312-1326, 2014. ,
Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches, Science, vol.363, issue.6432, p.964, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02358158
,
, Three unique interstitial macrophages in the murine lung at steady state, Am J Respir Cell Mol Biol, vol.57, issue.1, pp.66-76, 2017.
Non-classical tissue monocytes and two functionally distinct populations of interstitial macrophages populate the mouse lung, Nat Commun, vol.10, issue.1, p.3964, 2019. ,
,
Identification of a nerve-associated, lung-resident interstitial e1807836-16 ,
, macrophage subset with distinct localization and immunoregulatory properties, Sci Immunol, vol.5, issue.45, p.8756, 2020.
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Nat Med, vol.26, issue.6, pp.842-844, 2020. ,
Dynamics of human monocytes and airway macrophages during healthy aging and after transplant, J Exp Med, vol.217, issue.3, p.20191236, 2020. ,
Tissue-Resident Macrophages Limit Pulmonary CD8 Resident Memory T Cell Establishment, Front Immunol, vol.10, p.2332, 2019. ,
Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection, J Leukoc Biol, vol.95, issue.2, pp.215-224, 2014. ,
Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection, Mucosal Immunol, vol.8, issue.5, pp.1060-1071, 2015. ,
Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles, J Clin Invest, vol.128, issue.2, pp.721-733, 2018. ,
Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the lung airways and parenchyma, Mucosal Immunol, vol.11, issue.4, pp.1071-1078, 2018. ,
Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses, Immunity, vol.44, issue.6, pp.1379-1391, 2016. ,
Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells, Nat Immunol, vol.17, issue.1, pp.65-75, 2016. ,
Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses, Nat Immunol, vol.17, issue.1, pp.76-86, 2016. ,
Intestinal macrophages arising from CCR2(+) monocytes control pathogen infection by activating innate lymphoid cells, Nat Commun, vol.6, p.8010, 2015. ,
Gamma/delta T lymphocytes in viral infections, J Leukoc Biol, vol.58, issue.3, pp.277-283, 1995. ,
Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells, J Infect Dis, vol.193, issue.9, pp.1244-1249, 2006. ,
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8 + T cells, Nat Commun, vol.6, p.6833, 2015. ,
A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, vol.579, issue.7798, pp.270-273, 2020. ,
Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host, Nat Microbiol, vol.4, issue.5, pp.789-799, 2019. ,
Unlocking bat immunology: establishment of Pteropus alecto bone marrow-derived dendritic cells and macrophages, Sci Rep, vol.6, issue.1, p.38597, 2016. ,
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny, Nat Rev Immunol, vol.14, issue.8, pp.571-578, 2014. ,
Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome, Clin Immunol, vol.116, issue.3, pp.225-235, 2005. ,
Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells, J Virol, vol.83, issue.7, pp.3039-3048, 2009. ,
Age-related increases in PGD (2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice, J Clin Invest, vol.121, issue.12, pp.4921-4930, 2011. ,
Constitutive resistance to viral infection in human CD141 + dendritic cells, Sci Immunol, vol.2, issue.13, p.8071, 2017. ,
Mapping the human DC lineage through the integration of high-dimensional techniques, Science, vol.356, issue.6342, 2017. ,
Constitutive Siglec-1 expression confers susceptibility to HIV-1 infection of human dendritic cell precursors, Proc Natl Acad Sci U S A, vol.116, issue.43, pp.21685-21693, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02395893
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon, Blood, vol.109, issue.3, pp.1131-1137, 2007. ,
Systematic identification of type I and type II interferon-induced antiviral factors, Proc Nat Acad Sci, vol.109, issue.11, pp.4239-4244, 2012. ,
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients, Science, p.6027, 2020. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02900830
SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex, Protein Cell, vol.5, issue.5, pp.369-381, 2014. ,
Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3, Emerg Microbes Infect, vol.5, p.39, 2016. ,
Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains, mBio, vol.11, issue.2, 2020. ,
Role of leptin and SOCS3 in inhibiting the type I interferon response during obesity, Inflammation, vol.40, issue.1, pp.58-67, 2017. ,
,
, Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency, Science, vol.348, issue.6233, pp.448-453, 2015.
Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency ,
, J Exp Med, vol.215, issue.10, pp.2567-2585, 2018.
,
, Antiviral Res, vol.178, p.104791, 2020.
Interferon-?2b treatment for COVID-19, Front. Immunol, vol.11, p.1061, 2020. ,
Coronavirus virulence genes with main focus on SARS-CoV envelope gene, Virus Res, vol.194, pp.124-137, 2014. ,
Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles moscona A, editor. mBio, vol.4, pp.524-537, 2013. ,
Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection, mBio, vol.6, issue.3, pp.638-00615, 2015. ,
Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3. Virology, vol.515, pp.165-175, 2018. ,
The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists, Protein Cell, vol.4, issue.12, pp.951-961, 2013. ,
Towards formal representation and evaluation of arguments, Argumentation, vol.28, issue.3, pp.379-393, 2014. ,
Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice, Cell Host Microbe, vol.19, issue.2, pp.181-193, 2016. ,
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome, J Virol, vol.81, issue.16, pp.8692-8706, 2007. ,
Bach2 deficiency leads to spontaneous expansion of IL-4-producing T follicular helper cells and autoimmunity, Front Immunol, vol.10, p.2050, 2019. ,
,
, High secretion of interferons by human plasmacytoid dendritic cells upon recognition of middle east respiratory syndrome coronavirus perlman S, editor, J Virol, vol.89, issue.7, pp.3859-3869, 2015.
Intranasal treatment with Poly(I{middle dot}C) protects aged mice from lethal respiratory virus infections, J Virol, vol.86, issue.21, pp.11416-11424, 2012. ,
Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity, J Immunol, vol.193, issue.3, pp.1324-1332, 2014. ,
MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV Subbarao K, editor, PLoS Pathog, vol.4, issue.12, p.1000240, 2008. ,
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection, JCI Insight, vol.4, issue.20, p.131774, 2019. ,
SARS-CoV-2: virus dynamics and host response, Lancet Infect Dis, pp.30235-30243, 2020. ,
Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays, Clin Chem, vol.50, issue.1, pp.67-72, 2004. ,
Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury, Cell, vol.133, issue.2, pp.235-249, 2008. ,
Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto, Sci Rep, vol.6, p.37796, 2016. ,
T cell-mediated immune response to respiratory coronaviruses, Immunol Res, vol.59, issue.1--3, pp.118-128, 2014. ,
Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways, J Infect Dis, vol.213, issue.6, pp.904-914, 2016. ,
Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice, PLoS Pathog, vol.5, issue.10, p.1000636, 2009. ,
IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections, J Immunol, vol.176, issue.7, pp.4284-4295, 2006. ,
Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin Infect Dis, 2020. ,
Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19, J Infect, 2020. ,
T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice, JVI, vol.84, issue.18, pp.9318-9325, 2010. ,
Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection, J Immunol, vol.156, pp.3342-3349, 1996. ,
Mucosal resident memory CD4 T cells in protection and immunopathology, Front Immunol, vol.5, p.331, 2014. ,
Expanding roles for CD4+ T cells in immunity to viruses, Nat Rev Immunol, vol.12, issue.2, pp.136-148, 2012. ,
Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection, J I, vol.187, issue.11, pp.5510-5514, 2011. ,
Immunological responses against SARS-coronavirus infection in humans, Cell Mol Immunol, vol.1, pp.119-122, 2004. ,
T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS, J Virol, vol.78, issue.11, pp.5612-5618, 2004. ,
Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients, Clin Immunol, vol.120, issue.2, pp.171-178, 2006. ,
Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients, Virology, vol.351, issue.2, pp.466-475, 2006. ,
Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope, J Virol, vol.85, issue.20, pp.10464-10471, 2011. ,
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease, Nat Commun, vol.9, issue.1, p.824, 2018. ,
IFITM3 restricts the morbidity and mortality associated with influenza, Nature, vol.484, issue.7395, pp.519-523, 2012. ,
Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection, Proc Natl Acad Sci, vol.111, issue.2, pp.769-774, 2014. ,
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients, Nat Med, vol.5, issue.4, pp.423-426, 1999. ,
Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis, PLoS Negl Trop Dis, vol.4, issue.10, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02292512
Human Ebola virus infection results in substantial immune activation, Proc Natl Acad Sci, vol.112, issue.15, pp.4719-4724, 2015. ,
Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals, Cell, vol.181, issue.7, pp.1489-1501, 2020. ,
Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19), Infect. Dis, p.2020 ,
Viral and host factors related to the clinical outcome of COVID-19, Nature, 2020. ,
Thymosin alpha 1 (T?1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells, Clin Infect Dis, 2020. ,
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications, Science, p.8511, 2020. ,
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections, Cell Rep, vol.18, p.107725, 2020. ,
A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2, Cell Host Microbe, vol.27, issue.4, pp.671-680, 2020. ,
Selective and crossreactive SARS-CoV-2 T cell epitopes in unexposed humans, Science, p.3871, 2020. ,
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls, Nature, 2020. ,
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19), Proc Natl Acad Sci, 2009. ,
Significantly improved COVID-19 outcomes in countries with higher BCG vaccination coverage: a multivariable analysis. Vaccines (Basel), vol.8, p.3, 2020. ,
Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study, 2020. ,
Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19, Sci. Adv, vol.6, issue.32, p.1463, 2020. ,
Acute lower respiratory infection among bacille calmette-guérin (BCG)-vaccinated children, Pediatrics, vol.133, issue.1, pp.73-81, 2014. ,
BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study, J Infect Dis, vol.212, issue.12, pp.1930-1938, 2015. ,
SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults, JAMA, p.2020 ,
,
Therapeutic targeting of trained immunity, Nat Rev Drug Discov, vol.18, issue.7, pp.553-566, 2019. ,
Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ ,
, CD8+ T cells promote cellular immune responses, Vaccine, vol.25, pp.6981-6991, 2007.
Deciphering the TCR repertoire to solve the COVID-19 Mystery, Trends Pharmacol Sci, vol.41, issue.8, pp.518-530, 2020. ,
Clinical and immune features of hospitalized pediatric patients with coronavirus disease 2019 (COVID-19) in Wuhan, China, JAMA Netw Open, vol.3, issue.6, p.2010895, 2020. ,
Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19, J Med Virol, 2020. ,
Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation. medRxiv, 2020. ,
Therapeutic Potential of B-1a Cells in COVID-19. Shock, 2020. ,
A single-cell atlas of the peripheral immune response to severe COVID-19. medRxiv, 2020. ,
Nextgeneration sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease, Immunity, 2020. ,
Molecular basis of the differentiation and function of virus specific follicular helper CD4+ T Cells, Front Immunol, vol.10, p.249, 2019. ,
The regulation and role of T follicular helper cells in immunity, Immunology, vol.134, issue.4, pp.361-367, 2011. ,
Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses, Immunity, vol.39, issue.4, pp.758-769, 2013. ,
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19, Nat Med, 2020. ,
, Germinal center B Cell dynamics. Immunity, vol.45, issue.3, pp.471-482, 2016.
,
, Clinical virology of ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among Ehf patients in KikWit, democratic republic of the congo, J Infect Dis, vol.179, issue.s1, pp.177-187, 1995.
,
, Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit, J Infect Dis, vol.179, issue.1, pp.28-35, 1999.
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide, J Clin Microbiol, vol.42, issue.12, pp.5885-5888, 2004. ,
Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses, J Infect Dis, vol.209, issue.7, pp.995-1006, 2014. ,
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants, J Virol, vol.79, issue.10, pp.5900-5906, 2005. ,
,
, Infectious Middle East respiratory syndrome coronavirus excretion and serotype variability based on live virus isolates from patients in Saudi Arabia, J Clin Microbiol, vol.53, issue.9, pp.2951-2955, 2015.
Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection, J Virol, vol.88, pp.11034-11044, 2014. ,
,
, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, vol.361, issue.9371, pp.1767-1772, 2003.
Profiling early humoral response to diagnose novel coronavirus disease (COVID-19), Clin Infect Dis, 2020. ,
Evaluation of nucleocapsid and spike protein-based ELISAs for detecting antibodies against SARS-CoV-2, J Clin Microbiol, 2020. ,
,
, Virological assessment of hospitalized patients with COVID-2019, Nature, 2020.
Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset, Eur Respir J, 2020. ,
Evaluating serological status of COVID-19 patients using an indirect immunofluorescent assay, France, Eur J Clin Microbiol Infect Dis, 2020. ,
Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients, Emerg Infect Dis, vol.26, issue.7, 2020. ,
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients. Emerg Microbes Infect, vol.20, pp.1-14, 2020. ,
,
, Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection, JCI Insight, vol.4, issue.4, 2019.
Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, vol.181, issue.2, pp.281-292, 2020. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02546518
A serological assay to detect SARS-CoV-2 seroconversion in humans, Nat Med, vol.26, issue.7, pp.1033-1036, 2020. ,
,
, Convergent antibody responses to SARS-CoV-2 in convalescent individuals, Nature, 2020.
Treatment of 5 critically ill patients with COVID-19 with convalescent plasma, JAMA, 2020. ,
Use of convalescent plasma therapy in SARS patients in Hong Kong, Eur J Clin Microbiol Infect Dis, vol.24, issue.1, pp.44-46, 2005. ,
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection, Clin Infect Diseases, vol.52, issue.4, pp.447-456, 2011. ,
Treatment with convalescent plasma for influenza A (H5N1) infection, N Engl J Med, vol.357, issue.14, pp.1450-1451, 2007. ,
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience, Antivir Ther, vol.23, issue.7, pp.617-622, 2018. ,
Evaluation of convalescent plasma for ebola virus disease in guinea, N Engl J Med, vol.374, issue.1, pp.33-42, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01252702
Administration of brincidofovir and convalescent plasma in a patient with ebola virus disease, Clin Infect Dis, vol.61, issue.6, pp.969-973, 2015. ,
Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Natl Acad Sci, 2020. ,
Replicationcompetent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis. bioRxiv, 2020. ,
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial, Lancet, vol.395, pp.31208-31211, 2020. ,
Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection. bioRxiv, 2020. ,
An mRNA vaccine against SARS-CoV-2 -preliminary report, N Engl J Med, 2020. ,
, NIH clinical trial of investigational vaccine for COVID-19 begins, 2020.
Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus, Hum Vaccin Immunother, vol.11, issue.5, pp.1244-1250, 2015. ,
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease, Virus Res, vol.133, issue.1, pp.45-62, 2008. ,
A comparative study of techniques for differential expression analysis on RNA-Seq data provero P, editor, PLoS ONE, vol.9, issue.8, p.103207, 2014. ,
Middle East respiratory syndrome: obstacles and prospects for vaccine development, Expert Rev Vaccines, vol.14, issue.7, pp.949-962, 2015. ,
Sola Basis of Coronavirus Virulence and Vaccine Development, Adv. Virus Res, vol.96, pp.245-286, 2016. ,
A human monoclonal antibody blocking SARS-CoV-2 infection, Nat Commun, vol.11, issue.1, p.2251, 2020. ,
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody, Emerg Microbes Infect, vol.9, issue.1, pp.382-385, 2020. ,
Structural and functional analysis of a potent sarbecovirus neutralizing antibody ,
, , 2009.
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19. medRxiv, 2020. ,
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients, Cell, 2020. ,
Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir Med, 2020. ,
The clinical pathology of severe acute respiratory syndrome (SARS): a report from, China. J Pathol, vol.200, issue.3, pp.282-289, 2003. ,
,
ings of a fatal case of Middle East respiratory syndrome coronavirus infection in the united arab emirates, Am J Pathol, vol.186, issue.3, pp.652-658, 2014. ,
CD4 T cell-restricted IL-2 signaling defect in a patient with a novel IFNGR1 deficiency, J Allergy Clin Immunol, vol.141, issue.1, pp.435-439, 2018. ,
CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination, J Immunol, vol.165, issue.4, pp.2278-2286, 2000. ,
Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis, J Immunol, vol.186, issue.6, pp.3642-3652, 2011. ,
Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10, Nat Med, vol.15, issue.3, pp.277-284, 2009. ,
Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?, Viruses, vol.4, issue.5, pp.833-846, 2012. ,
Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells, Virology, vol.353, issue.2, pp.474-481, 2006. ,
Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8+ T cells, Sci Rep, vol.6, issue.1, p.35997, 2016. ,
Functional exhaustion of antiviral lymphocytes in COVID-19 patients, Cell Mol Immunol, 2020. ,
Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults, Blood, vol.135, issue.11, pp.826-833, 2020. ,
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med, 2020. ,
The role of interleukin-6 in monitoring severe case of coronavirus disease 2019, EMBO Mol Med, vol.12, issue.7, p.12421, 2020. ,
The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes, 20045427. ,
Clinical and pathological investigation of severe COVID-19 patients, JCI Insight, 2020. ,
Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19), Br J Haematol, vol.190, issue.2, pp.179-184, 2020. ,
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, vol.18, issue.4, pp.844-847, 2020. ,
Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies, Ann Hematol, 2020. ,
An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19, Lancet, pp.31526-31535, 2020. ,
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad, Clin Rheumatol, 2020. ,
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19, Ann Intern Med, 2020. ,
Neutrophil Extracellular Traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome, 2020. ,
Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients, Clin Infect Dis, 2020. ,
D-dimer is associated with severity of coronavirus disease 2019: a Pooled Analysis, Thromb Haemost, vol.120, issue.5, pp.876-878, 2020. ,
,
, Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19, N Engl J Med, vol.383, issue.2, pp.120-128, 2020.
Endothelial cell infection and endotheliitis in COVID-19, Lancet, vol.395, issue.20, pp.30937-30942, 2020. ,
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study, Lancet Haematol, pp.30216-30223, 2020. ,
Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2, Int J Lab Hematol, 2020. ,
Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis, J Thromb Haemost, vol.18, issue.7, pp.1738-1742, 2020. ,
The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease, Autoimmun Rev, vol.19, issue.6, p.102537, 2020. ,
COVID-19: the vasculature unleashed, Nat Rev Immunol, vol.20, issue.7, pp.389-391, 2020. ,
,
, Suppressive myeloid cells are a hallmark of severe COVID-199, Cell, p.2020
Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration*, Crit Care Med, vol.42, issue.9, pp.2007-2018, 2014. ,
Increased granulopoiesis in the bone marrow following Epstein-Barr virus infection, Sci Rep, vol.9, issue.1, p.13445, 2019. ,
Current gaps in sepsis immunology: new opportunities for translational research, Lancet Infect Dis, vol.19, issue.12, pp.30567-30572, 2019. ,
Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV, Emerg Microbes Infect, vol.7, issue.1, p.77, 2018. ,
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis Subbarao K, editor. mBio, vol.9, pp.1753-1771, 2018. ,
The H7N9 influenza A virus infection results in lethal inflammation in the mammalian host via the NLRP3-caspase-1 inflammasome, Sci Rep, vol.7, issue.1, p.7625, 2017. ,
Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury, J Clin Invest, vol.122, issue.7, pp.2661-2671, 2012. ,
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood, Nat Med, vol.13, issue.4, pp.463-469, 2007. ,
Extracellular DNA traps promote thrombosis, Proc Nat Acad Sci, vol.107, issue.36, pp.15880-15885, 2010. ,
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases, Nat Med, vol.16, issue.8, pp.887-896, 2010. ,
Neutrophils scan for activated platelets to initiate inflammation, Science, vol.346, issue.6214, pp.1234-1238, 2014. ,
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo, J Exp Med, vol.209, issue.4, pp.819-835, 2012. ,
Cooperative PSGL-1 and CXCR2 signaling in neutrophils promotes deep vein thrombosis in mice, Blood, vol.132, issue.13, pp.1426-1437, 2018. ,
Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials, Rheumatology (Oxford), vol.11, issue.1, pp.541-549, 2017. ,
,
, Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report, Ann Oncol, 2020.
Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab, Am J Hematol, 2020. ,
Tocilizumab treatment in COVID-19: A single center experience, J Med Virol, 2020. ,
,
, Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev, 2020.
Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Natl Acad Sci, 2020. ,
Use of tocilizumab for COVID-19-induced cytokine release syndrome: a cautionary case report, 2020. ,
Gastrointestinal perforation after treatment with tocilizumab : an unexpected consequence of COVID-19 pandemic, Am Surg, vol.86, issue.6, pp.565-566, 2020. ,
Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19, Clin Infect Dis, 2009. ,